Paradoxically, loss of immunoglobulin A (IgA), one of the most abundant antibodies, does not irrevocably lead to severe infections in humans but rather is associated with relatively mild respiratory infections, atopy, and auto immunity. IgA might therefore also play covert roles, not uniquely associated with control of pathogens. We show that human IgA deficiency is not associated with massive quantitative perturbations of gut microbial ecology. Metagenomic analysis highlights an expected pathobiont expansion but a less expected depletion in some typi cally beneficial symbionts. Gut colonization by species usually present in the oropharynx is also reminiscent of spatial microbiota disorganization. IgM only partially rescues IgA deficiency because not all typical IgA targets are efficiently bound by IgM in the intestinal lumen. Together, IgA appears to play a nonredundant role at the fore front of the immune/microbial interface, away from the intestinal barrier, ranging from pathobiont control and regulation of systemic inflammation to preservation of commensal diversity and community networks.
INTRODUCTION
Eukaryotes have developed spectacular ways not only to protect themselves from pathogens but also to benefit from unique and essential features of surrounding organisms (symbionts). Mammals are indeed highly dependent on their consortia of symbionts (microbiota) that serve both to optimize processing of nutrients and to protect from opportunistic agents by competition. Innate immune mechanisms controlling host-microbiota mutualism are physically localized, activated by bacterial contact, culminating into breach of the gut mucosal firewall. Immediate nonspecific host responses involve the secretion of defensins and the intraluminal recruitment of innate immune cells such as neutrophils that encapsulate commensals and limit their contact with surrounding gut epithelium (1) . Such a potent response comes with a fitness cost to the commensal community and the benefits this brings to the host. It is therefore postulated that an evolutionary pressure took place to acquire mechanisms acting in the lumen, which would regulate microbial communities, thereby reducing the frequency of breaching the gut barrier and activation of innate immunity. This role could be played by antibodies and, most likely, by secretory immunoglobulin A (IgA) (2, 3) . However, whereas antibody responses to pathogens have been intensively studied, much less interest has been devoted to the study of antibody relations with symbionts. Murine models of IgA deficiency (IgAd) have been studied and display modifications of the microbiome-immune interface. In such models, IgAd was obtained by inducing (i) defects in IgA class switch recombination (CSR) (4-6), (ii) defects in IgA transport into the gut lumen [pIgR −/− mice (7, 8) and J-chain −/− mice (9) ], or (iii) reduction of IgA repertoire diversity without altering IgA levels [(activation-induced cytidine deaminase knockin mutation (10) , PD-1 −/− mice (11) , and FoxP3 + CD4 + -depleted mice (12) ]. Models impairing CSR mechanisms (i) are associated with a gut dysbiosis defined by an expansion of anaerobes, predominantly segmented filamentous bacteria (SFB) and Clostridiales, as well as nodular hyperplasia secondary to hyperactivation of germinal center B cells induced by microbial antigens (4, 5) . Models impairing IgA secretion (ii) into the gut lumen were associated with altered microbiota composition, increased susceptibility to induced colitis, higher bacterial translocation to mesenteric lymph nodes after Salmonella typhimurium challenge, and lack of protective immunity against cholera toxin (7, 8) . Notably, alterations of gut microbiota ecosystems were observed in the small intestine, whereas large intestine communities were much less affected by the absence of IgA (5), possibly because IgA predominantly targets commensal bacteria in the small intestine, but not in the colon, as shown by Bunker et al. (13) both in mice and in humans. Together, altered microbiome composition, increased susceptibility to microbial translocation, reduced microbial diversity, and reduced microbial fitness are shared features of IgA deficiency models.
These results are in line with the initial conception of IgA function, mainly presented as a neutralizing antibody, whose role would mainly be to exclude potentially harmful microbes and toxins from intimate contact with intestinal epithelia, thereby preserving mucosal barrier integrity (14) . IgAd is relatively common in human adults, occurring in about 1 in 500 Caucasian individuals (15, 16) . Although human selective IgA deficiency (SIgAd) (that is, patients deficient for IgA but sufficient for all other antibody isotype) was, for a long time, considered asymptomatic, recent longitudinal studies have revealed that 80% of patients are symptomatic, when assessing complications more broadly (17) or when follow-up is extended (18) . Human IgAd is associated with recurrent mucosal infections, autoimmunity, and intestinal disorders such as inflammatory bowel disease (IBD) and lymphoid hyperplasia (19, 20) . To explain the mild phenotype observed in SIgAd patients, it is proposed that IgM may effectively replace IgA as the predominant antibody in secretions (21, 22) . However, if IgA indeed represents a merely redundant component of the immune system, then it appears paradoxical that it was so well conserved in evolution and that it is massively produced at the individual level [about 66 mg/kg per day of IgA is secreted everyday (23) ]. IgA also appears to orchestrate the beneficial tolerance established between the host and its gut commensal microbiome. These mutualistic host-microbial relationships were emphasized in animal models with an immune system reduced to a single monoclonal antibody of known bacterial specificity challenged by a limited microbial diversity. Although antibody binding was reducing bacterial fitness, it also resulted in reduced intestinal production of proinflammatory signals, hence allowing bacterial tolerance by the host (24) . Similarly, flagellin-specific secretory IgA (sIgA) may promote tolerance by reducing bacterial motility through modulation of flagellin transcription (25) .
Although these models have provided important examples and possible mechanisms through which antibodies can imprint specific microbes, the targets of polyclonal IgA and their global impact on the microbiome remain poorly defined. Although it was recently shown in an animal model that IgA-coated bacteria include proinflammatory elements (26), it is not known whether IgA preferentially binds potentially harmful bacteria and/or commensals (27) . It is not known either whether IgM can indeed replace IgA at no expense to host/ bacterial homeostasis. Finally, the relations between SIgAd and systemic autoimmunity are not well understood.
Here, we studied the composition of sIgA-bound gut microbiota in healthy individuals and evaluated alterations of this bacterial consortium in SIgAd patients. To get insights into the specific contributions of IgA on host/microbial symbiosis, we also explored systemic immune responses in these patients.
RESULTS
Patients lacking IgA-producing B cells and seric IgA also lack free and bacteria-bound digestive IgA SIgAd represents a bioclinical entity that is defined by serologic means, namely, undetectable seric IgA titers (<0.07 mg/ml) with normal IgG concentration (28) . SIgAd patients are known to present low or undetectable salivary IgA levels (21, 22) , but their gut IgA status had not been assessed. We serologically confirmed a status of IgA deficiency in 21 patients that could be included in this study because, among other exclusion criteria, they did not receive antibiotic treatment 3 months before inclusion. Compared to age-and sex-matched healthy donors (HDs) (n = 34), these SIgAd patients had undetectable seric ( fig. S1A ) and scarce digestive IgA levels [43 (0 to 206) g in HDs versus 0 (0 to 21) g of free IgA per gram of stool in SIgAd, P < 0.0001; Fig. 1A Fig. 1C ]. These data show that sIgA deficiency affects both peripheral blood and distant organs, such as the intestine, at both the cellular and the protein level.
The clinical spectrum of digestive SIgAd-associated symptoms varies from very mild to severe, and it remains unknown whether residual digestive IgA would account for pauci-symptomatic presentations. We therefore used a flow cytometry assay, derived from our previously published technology (29) , to test whether traces of IgA might be detected at the surface of the fecal microbiota, although free digestive IgA is usually not detectable in SIgAd, as shown above. The protocol was modified to assess levels of mucosal antibodies targeting colonic microbiota in vivo (Fig. 1D) . IgA, as the main mucosal antibody in HDs, binds a median percentage of 7.6 (0.8 to 17.6)% of the whole fecal microbiota (Fig. 1D ). Close examination of flow cytometry profiles also reveals that IgA-bound microbiota can be subdivided into IgA dim and IgA bright bacterial populations (Fig. 1D , left). These IgA + subsets were absent in all SIgAd patients except one (P < 0.0001; Fig. 1D, right) . Notably, this patient also had detectable IgA + circulating B cells (Fig. 1B) . This interesting case confirms that some patients diagnosed with SIgAd by serologic means indeed retain sIgA, which can be detected by the very sensitive bacterial flow cytometry technique. These data nevertheless establish that microbiota-bound IgA is usually undetectable in SIgAd patients.
Global microbiome diversity is preserved in SIgAd patients
To study the global impact of digestive IgA deficiency on the gut microbiome, we performed shotgun sequencing (30, 31) of fecal samples in 34 HDs and 17 SIgAd patients. High-quality reads from each sample were mapped to a reference catalog of 3.9 million genes (32) . Taxonomic abundances were computed at the level of co-abundance gene groups (CAGs) and, subsequently, binned at broader taxonomic levels (genus, family, order, class, and phylum). CAGs contain at least 50 different genes. Metagenomic species (MGSs) are defined as larger CAGs with very high connectivity and a defined minimal size of at least 700 genes. This approach to study microbiome composition presents the advantage to overcome the limited resolution of previous methods used for metagenomic or 16S amplicon data analysis that rely on comparisons to reference genomes, offering the possibility to comprehensively profile the diversity of a clinical sample and to potentially identify previously uncharacterized microbes (32) .
Metagenomic analysis revealed a similar representation of the dominant phyla in the two groups [HDs versus SIgAd: 44.55% versus 45.52% (P = 1) for Bacteroidetes, 50.52% versus 48.35% (P = 0.7774) for Firmicutes, 2.19% versus 3% (P = 1) for Proteobacteria, 0.65% versus 0.84% (P = 0.99) for Actinobacteria, and 1.5% versus 1.41% (P = 1) for unclassified phyla; fig. S2A fig. S2C ]. To estimate the stability of the gut microbiota profiles, we analyzed the gut microbiota composition of three healthy subjects sampled longitudinally (two samples, 12 months apart). Hierarchical cluster analysis outlines strong structural intraindividual sample proximity, suggesting overall temporal stability of individual gut microbiota profiles, at least in healthy subjects ( fig. S3 ). Together, these data reveal that the diversity of SIgAd and control fecal bacterial repertoires does not differ significantly. Our data also suggest that an individual's profile remains stable over time.
IgA deficiency gut microbiota displays mild dysbiosis
We reasoned that IgA deficiency might affect relatively discrete bacterial populations, without affecting global microbiome structure at the analysis level applied above. A gene biomarker approach (33) was used to determine which bacteria were expanded or depleted in IgA deficiency, comparing the whole unsorted microbiota of 34 HDs with 17 SIgAd patients ( fig. S4 ). We found 31 differential MGSs between the two groups; 17 being were overrepresented, whereas 14 were underrepresented in SIgAd patients. Differential MGSs, between controls and patients, were ranked according to increasing statistical significance ( Fig. 2A) . Most MGSs depleted in IgA deficiency (13 of 14) belong to the Firmicutes phylum, whereas only one belongs to the Bacteroidetes phylum. Among depleted Firmicutes, more than half of them (7 of 13) belong to the Lachnospiraceae family, and two are Ruminococcaceae (Faecalibacterium genus, n = 2 of 2) (Fig. 2B) .
Conversely, among the 17 expanded MGSs in IgA deficiency, 10 are Firmicutes, 4 are Bacteroidetes, and 3 are Proteobacteria (Gammaproteobacteria exclusively, including Escherichia coli). These 17 MGSs belong to 11 different families and, thus, are more diverse than depleted species. Three of seventeen expanded MGSs are usually present in the oropharynx flora (Streptococcus sanguinis, Veillonella parvula, and Haemophilus parainfluenzae). In addition, we found two different species of Prevotella to be overrepresented in SIgAd (compare Fig. 2A ).
IgA targets more likely decline than expand in the absence of IgA
We then postulated that microbial ecology perturbation in the absence of IgA might be appreciated in a different manner if we could focus on bacteria, more specifically, IgA-targeted in healthy controls. We previously verified that metagenomic analysis could reliably be performed on sorted bacterial subsets with a determined lowest analyzable sample size of 10 8 bacteria (34) . IgA + fractions were enriched by magnetic sorting in 30 healthy controls, allowing IgA + and IgA − fraction sequencing and differential metagenomic analysis (Fig. 3A) . The same gene biomarker identification approach as above ( fig. S4 ) allowed the identification of 24 different MGS overrepresented in the IgA + fraction of healthy controls ( fig. S5 ). These "IgA + MGSs" were ranked according to increasing statistical significance at the lowest taxonomic level available (Fig. 3B ). Among the 24 IgA + MGSs, 19 belong to the Firmicutes phylum (among which 12 belong to the Clostridia class, 1 of these 12 belonging to the Faecalibacterium genus), 2 are bacteria from unclassified phylum, 1 is Proteobacteria (one E. coli species), 1 belongs to the Actinobacteria phylum (Bifidobacterium bifidum), and the last identified MGS belong to the Bacteroidetes phylum (Fig. 3C) . We finally compared the prevalence of IgA + MGSs between SIgAd patients and controls and found that the prevalence of only four of them was significantly altered (Fig. 3D) . Whereas E. coli (CAG 4) was 
IgM digestive secretion partially rescues microbiota antibody coating in SIgAd patients
We then postulated that compensatory immune mechanisms might explain why IgA deficiency is not associated with massive perturbations of gut microbial ecology, as previously suggested (21, 22, 35) . Microbial flow cytometry analysis was used to detect other antibody isotypes on the surface of SIgAd microbiomes. IgM was indeed detected at the surface of SIgAd microbiota in all SIgAd patients analyzed ( 
S C I E N C E T R A N S L A T I O N A L M E D I C I N E | R E S E A R C H A R T I C L E

of 15
In blood, so-called IgM-only B cells (36) significantly different between HDs and SIgAd patients. Horizontal lines represent medians, and P values were calculated with a Mann-Whitney test. Significant differences were indicated with *P < 0.05, **P < 0.025, and ***P < 0.01. are equally present in both fractions (Fig. 4D, bottom) . Paired analysis performed on these 19 taxa revealed that Clostridium and Pseudomonas genera are significantly enriched in the IgM + fraction (P = 0.013). Bacteria belonging to the Enterobacteriaceae family are poorly bound by IgM. Together, not all typical IgA targets are bound by digestive IgMs in SIgAd patients (Fig. 4E) . Fig. 5D ). Together, the data suggest that, in the absence of intestinal IgA, IgM binding preserves Actinobacteria diversity, although this conclusion needs to be validated on a larger CVID cohort.
IgM responses are correlated with commensal diversity in IgA deficiency
Given that the recent literature substantiates that IgA shapes microbiota composition and diversity in mice (12), we wanted to know whether IgM could play this role in IgA deficiency. Median gut IgM + enrichment ratios
IgA deficiency is associated with systemic inflammation
We then asked whether the lack of sIgA could induce perturbations in host systemic inflammatory versus regulatory responses, in spite of the presence of mucosal IgM responses. Cytokine-secreting circulating CD4 + T cells were measured in both groups ( ) was similar between patients and controls (Fig. 6D) . Thus, SIgAd patients display a circulating skewed CD4 + T cell phenotype toward T helper 17 (T H 17) differentiation associated with an increase of seric sCD14, which is a marker of monocyte activation. Patients with malabsorption were excluded from the study because mucosal defects might grossly affect gut microbial ecology. We stratified patients in an effort to determine whether other clinical features such as infection, autoimmunity, or historic antibiotic treatments (at least 3 months before sampling) might be preferentially associated with inflammation. We found no correlations between clinical status and any of the elevated immunological markers mentioned above (Fig. 6, A to  D) . Together, the immunological and inflammatory modifications associated with SIgAd are not contributed by isolated patients presenting "extreme" clinical phenotypes.
IgA deficiency is associated with a disturbed bacterial dependency network
Bacterial symbiosis in the human gut notably implies that some bacteria depend on other bacteria for their persistence. Within such networks, and by definition, a dependent bacterium, called "satellite," never occurs independently of another, coined "host," in a given sample. Conversely, the same host may occur in a given sample independently of its satellites (Fig. 7A) . This concept was initially promoted by Nielsen et al. (32) , who identified a minimal obligatory network of 45 MGS-MGS dependency associations involving 60 MGSs (the same MGS can make several associations). To investigate the potential impact of IgA deficiency on bacterial dependency associations, we tested whether this minimal obligatory network was disturbed in IgA deficiency.
Main links defined by Nielsen et al. (32) were confirmed in HDs (90 to 100%), whereas the confirmed link percentage was more dispersed in SIgAd patients, ranging from 75 to 100% (Fig. 7B) . On the basis of our HD MGS-MGS co-presence distribution, the 99% confidence interval was calculated according to a  distribution defining a lower threshold of 84% of MGS-MGS co-presence, below which the population-level link was considered absent. In our HD cohort, 41 of 45 links were maintained at population level, whereas only 30 links were confirmed in SIgAd patients. The 11 links lost in SIgAd patients involved 21 MGS: 7 Faecalibacterium sp., 4 Firmicutes, 2 Clostridiales, 2 Ruminococcus sp., 2 Prevotella, 2 Butyricimonas virosa, and 2 unknown MGSs (data file S1).
The resulting network of remaining bacterial dependencies for HDs and SIgAd patients is shown in Fig. 7C . In summary, IgA deficiency is associated with a disturbed bacterial dependency association network.
DISCUSSION
Similar to what was observed in murine models of IgAd (5), we found that IgA deficiency does not markedly alter global fecal microbiota composition in affected patients. However, our observations are limited to feces, and a more severe dysbiosis may be present in the small intestine, as shown in mouse models of IgA deficiency (5, (11) (12) (13) . The combination of flow cytometry and metagenomic analysis proved useful to increase the resolution of the analysis on human fecal samples by monitoring alterations of commensals specifically bound by sIgA in healthy controls. More work will be necessary to determine whether IgA dim and IgA bright bacterial populations correspond to bacteria bound by high-versus low-affinity IgA, respectively, and whether these subsets have overlapping bacterial repertoires or not. Notably, IgA interactions with very low affinity are also suggested and could account for the very discrete, but global, bacterial flow cytometry profile shift consistently observed in HDs but not observed in SIgAd patients.
It could have been expected that commensals bound by sIgA in healthy subjects would all tend to expand in IgAd patients. In murine models of immune deficiency, IgA targets, such as SFB (26) , expand in the absence of an effective IgA response (4, 12) . We rather observed that MGSs defined in Fig. 3B as main IgA targets in controls do not systematically bloom in SIgAd patients. Most notably, C. comes (CAG 19) is underrepresented in SIgAd patients compared to controls. By contrast, another typical IgA target, such as E. coli (CAG 4), is overrepresented in SIgAd patients by an order of magnitude, compared to controls. These data suggest that E. coli (CAG 4) expansion in the microbiota could indeed be negatively influenced by sIgA, whereas C. comes thrives in the presence of sIgA. More generally, at the family level, we observe that IgA + bacteria are more likely found to be underrepresented than overrepresented in SIgAd patients. These data emphasize the protective role that sIgA directly (or indirectly) plays in humans on commensal ecology, as previously observed in animal models (12) .
Using the gene biomarker analytical approach described in Qin et al. (33) , we identified bacterial targets of sIgA in HDs by meta genomic analysis of microbiota preparations enriched for sIgA-bound commensals. Notably, enriched samples retained detectable levels of non-IgA-bound commensals. This analytical approach (33) was chosen, because it allows identification based on differential abundance, which is less sensitive to sample purity. We show that sIgA targets preferentially Firmicutes, Actinobacteria, and Proteobacteria, whereas Bacteroidetes are largely underrepresented compared to total microbiota composition. Only 1 of the 24 MGSs identified as preferred sIgA targets belongs to the Bacteroidetes phylum, despite its dominance in the human colon. Our results are consistent with previous mouse (12, 26) and human (26, (37) (38) (39) (40) studies. Although preferred IgA targets belong to the Firmicutes phylum, underrepresented bacteria in SIgAd patients are also Firmicutes, such as Faecalibacterium, a genus well known to exert anti-inflammatory effects on the gut mucosa (41) and which is notably depleted in IBDs (42, 43) . Conversely, potentially proinflammatory Gammaproteobacteria and Prevotella (44) are overrepresented in SIgAd patients.
Overrepresented bacteria are more diverse than underrepresented bacteria. Three MGSs usually belonging to the oral flora (V. parvula, S. sanguinis, and H. parainfluenzae) are overrepresented in gut microbiomes of SIgAd patients. These bacteria are involved in biofilm formation and could exert inflammatory effects (45, 46) . V. parvula has also been described as responsible for sepsis in an X-linked agammaglobulinemia patient (47) . Finally, the genera usually described as pathogenic in patients (Salmonella and Campylobacter) were not found to be overrepresented.
Overall, we observed depletion of anti-inflammatory species, an expansion of proinflammatory species, and a lower digestive tract localization of constituents of the oral flora in IgAd patients. It was recently shown that ectopic localization of human salivary microbiota can elicit severe gut inflammation in susceptible host animals (48) . It is therefore possible that ectopic oral microbiota could also exert a proinflammatory role in the context of SIgAd. Mechanisms underlying these findings are unknown, but one could speculate that sIgA, on the one hand, excludes (14, 49) and facilitates elimination of fast-growing pathobionts (50) . On the other hand, sIgA could protect commensals by agglutination (51) and by localizing these bacteria in a favorable habitat like the mucus (fig. S8 ). Finally, IgA-mediated "intraluminal trapping" effects should prevent intimate bacterial proximity with the epithelial barrier and, therefore, host inflammation and associated negative effects on commensals.
In SIgAd patients, we show that the microbiota remains substantially bound by IgM. This observation, together with the recent characterization of dually coated (IgA + IgM + ) mucus-embedded bacteria with increased richness compared to IgA-only-coated bacteria (52) , suggests that IgM may compensate IgA deficiency. We show that microbial IgM binding is highly variable between patients. When focusing the analysis on commensals bound by sIgA in healthy subjects, or on differential genera between healthy controls and SIgAd patients, we noticed that IgM, like IgA, tends to preferentially bind Clostridium, Bifidobacterium, and Faecalibacterium (all Gram-positive bacteria). However, we show that IgM does not bind Enterobacteriaceae, nor Prevotellaceae families, which are overrepresented in SIgAd patients and involved in proinflammatory events (44) . These data suggest that IgM is only partially efficient at controlling pathobionts, ‡Four SIgAd patients having received antibiotics within 3 months from sampling were excluded for gut microbiota analysis but were included in the immunological phenotype analysis (compare Fig. 6 ).
§Median dose of 10 mg/day.
accounting for the susceptibility to enteropathogens in SIgAd. Our data suggest that sIgA has the same positive impact at least on Firmicutes and Actinobacteria diversity in humans, whereas IgM would only favor the latter. Notably, the very narrow range of IgM binding to Firmicutes, and to some extent Proteobacteria, might have precluded identification of potential correlations between IgM binding and diversity in these phyla.
In an effort to determine whether Actinobacteria diversity would also be lost in the absence of IgM, we studied CVID gut microbiomes. We observed that Actinobacteria diversity is drastically decreased in CVID, an "IgM-deficient" model. Moreover, a similar trend is observed for Firmicutes. These results were confirmed in an independent CVID study. Jørgensen et al. (53) recently showed that CVID patients display dysbiotic gut microbiota with reduced  diversity, reduced abundance of Actinobacteria, and increased abundance of Gammaproteobacteria. It should be underlined that, although we took care to include CVID that did not receive antibiotics within 3 months before sampling, the analysis of CVID patients is potentially hampered by several confounders such as previous antibiotic courses and other treatments. It is, however, interesting to note that Actinobacteria diversity is preferentially decreased in two independent CVID studies, whereas other phyla are comparatively less affected in this IgM-deficient cohort, while, allegedly, confounding factors might have similarly affected all phyla. There is clinical relevance for this concept because it is well established that patients selectively lacking IgA rarely develop IBD, whereas this complication is more frequent and severe in those lacking both IgA and IgM (54) .
The impact of IgA deficiency on bacterial symbiosis is further evidenced by the perturbation of bacterial networks. The presence in SIgAd patients of satellite bacteria (such as CAG 97, CAG 133, CAG 488, CAG 206, and CAG 328), in the absence of their previously described host (32) , most probably reflects the establishment of novel dependency links. Such modifications underscore the role played by IgA well beyond its recognized neutralizing activity.
SIgAd has also profound systemic repercussions. The T H 17 bias that we observed is potentially connected to intestinal dysbiosis because Klemola et al. (55) have already shown the presence of activated T cells in gut mucosa of IgAd patients. As described by Perreau et al. (56) , in CVID, CD4 + PD-1 + cells are increased in SIgAd patients. Although LPS was not found to be elevated in SIgAd serum, increased sCD14 and PD-1 up-regulation could reflect T cell exhaustion induced by repeated bacterial translocation (57) . Finally, and from a therapeutic perspective, a much larger cohort of patients would be needed to extract a potentially beneficial microbial signature associated with elevated IL-10 observed in some patients.
Together, we show that SIgAd in humans is associated with a mild intestinal dysbiosis, characterized by expansion of proinflammatory bacteria, depletion of anti-inflammatory commensals, and a perturbation in the "obligatory" bacterial network. Dysbiosis could be partly explained by the fact that IgA deficiency is not totally compensated by IgM secretion and by the loss of a nonredundant chaperone-like effect of IgA on microbial diversity.
MATERIALS AND METHODS
Study design
Patients and controls
We conducted a cross-sectional study of patients with IgA deficiency compared to healthy controls. Fresh stool and blood samples were collected simultaneously at a single time point in 21 patients with SIgAd (table S1) and compared with 34 age-and sex-matched HDs (Table 1) . We furthermore recruited seven CVID patients with IgA, IgG, and/or IgM deficiency, thus displaying a global antibody production defect. Patients were recruited from two French referral centers of clinical immunology (Department of Clinical Immunology in Saint Louis Hospital and Department of Internal Medicine in Pitié-Salpêtrière Hospital, Paris), where they were followed for clinical manifestations associated with antibody deficiencies. IgAd patient's inclusion criteria were undetectable seric IgA levels (<0.07 mg/ml) in at least three previous samples in the past year. SIgAd is defined by serological means, namely, undetectable seric IgA titers (<0.07 mg/ml) with normal IgG levels. CVID patients are characterized by a marked decrease of seric IgG (at least 2 SD below the age-dependent mean) and a marked decrease in at least one of the isotypes IgM or IgA. For our study, we furthermore requested that the patients should be deficient in seric IgA (<0.07 mg/ml).
Exclusion criteria
Antibiotic therapy and laxative drugs use in the last 3 months before stool collection (inclusion for metagenomic analysis: 17 SIgAd patients, 7 CVID, and 34 HDs). Clinical and biological data were collected at inclusion time. Oral and written consent were obtained from patients before inclusion in the study.
Bioinformatical analysis CAGs matrix construction
The projection of genes into CAGs was performed using a predefined list of 7381 CAGs (32) . Every predefined CAG is a vector of genes ordered by increasing connectivity. For a bacterial genome, the most connected genes correspond to the marker genes present in all individuals carrying this organism (core genome). Starting with the gene frequency matrix, we projected the list of connected genes in each predefined CAG and extracted the corresponding frequency profile of the 50 most connected ones. Provided that at least 10% of marker genes are found, each frequency profile was used to compute the mean vector corresponding to the CAG frequency.
Differential CAGs identification
Genes from the gene profile matrix were used to identify those that were differentially abundant between the SIgAd patients and HD groups as described in (30) . Briefly, Wilcoxon tests were used to compute the probabilities that gene frequency profiles did not differ between SIgAd patients and HD groups by chance alone. Benjamini and Hochberg multiple-test correction was applied to the P values. By performing a selection based on a significance threshold of P < 0.01, we identified 18,025 genes that were differentially abundant between the two groups. The same method and P value were applied to identify the differentially abundant genes between the IgA + /IgA − fractions in HDs. We identified 110,558 genes that were differentially abundant between the two groups. In a second step, the differentially abundant genes were projected into CAGs defined in the 3.9 million genes catalog. To validate a differential CAG, we used a threshold with a minimum of 50 differentially abundant genes per CAG (CAGs are kept only if they are equal to or exceed 50 connected genes) including at least 10% of marker genes. The frequency profile of the 50 most connected genes was used to compute the mean vector corresponding to the CAG frequency. Of the 18,025 differential genes between SIgAd patients and HDs, 8191 fell into 33 CAGs composed of 53 to 997 genes after the projection step ( fig. S2B and data + fractions) by chance alone. Benjamini and Hochberg multiple-test correction was applied to the P values. The CAG taxonomical annotation was performed as previously described (58) .
Dependency associations
Dependency associations between CAGs were defined as described previously (32) . This analysis relies on the detection of CAGs that are systematically associated with other CAGs in n = 396 HDs. Briefly, dependencies between CAGs were based on their sample-wise overlapping detection. First, a Fisher exact test was used to identify statistically significant CAGs detection overlap. Second, the dependencies were validated only when the dependent CAGs were systematically observed with their associated host CAG. Thus, a dependent CAG, called satellite CAG, should never occur independently of the host CAG. Using these criteria, 886 dependencies were identified, most of which involved a small CAG as a satellite, corresponding to phage/bacteria or pan-genome/core-genome relationship. Moreover, 45 MGS-MGS dependency associations were detected, involving MGS as satellite and host microorganisms that may reflect bacterial symbiosis events. We have considered the 45 MGS-MGS dependency associations detected by Nielsen et al. (32) as a minimal obligatory network that should be retrieved in HDs, and we hypothesized that it could be disturbed in IgA deficiency. The presence of the 45 links was subsequently investigated in our cohort, and for each link, we have determined the frequency of its presence in both groups. On the basis of our HD frequency distributions, we have determined the 99% confidence interval according to the  distribution law defining a threshold of frequency of 84%, below which the link was considered significantly decreased at the population level. The investigation of the 45-link presence-absence profiles in our cohort allowed us to distinguish four possible situations. For each link and each individual, if the MGS satellite is present in the absence of the host MGS, we consider the link as lost. If the MGS satellite is present in the presence of the host MGS, then we consider the link as confirmed. If the MGS host is present in the absence of the satellite MGS or if the two are absent, then the situation is not taken into account (no information about the link).
Statistical analysis
Log 2 ratio of IgM + /IgM − bacterial abundances was performed at the lowest taxonomic identification level (genus or family) to analyze IgM + relative binding. Only dominant taxa were taken into account, that is, taxa that are present in at least 50% of the patients. Zero was normalized in pairs and adjusted to the lowest abundance of all taxa in the paired samples.
Flow cytometry analysis was performed using FlowJo (9.3.2) TreeStar software and datamined with Funky Cells ToolBox software (version 0.1.2; www.FunkyCells.com). Statistical nonparametric tests were used whenever necessary: Mann-Whitney was used when comparing two groups, Kruskal-Wallis with multiple comparisons posttest of Dunn's was used when comparing three groups or more, Fisher's exact test was used for contingency, Wilcoxon paired rank test was used for paired analysis, and Spearman coefficient was used for correlations. R v3.2.1 and GraphPad Prism version 6 were used to perform statistical analysis. 
SUPPLEMENTARY MATERIALS
